Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
Phase II trial of oxaliplatin in combination with S-1(SOX) in patients with recurrent or
metastatic breast cancer (MBC) previously treated with or resistant to an anthracycline and
taxane
Phase:
Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
Asan Medical Center Korean Cancer Study Group National Cancer Center, Korea Samsung Medical Center Seoul National University Bundang Hospital Severance Hospital